AFP and hepatocellular carcinoma: Furthermore, a cohort study by El-Serag et al. [54] examining the effectiveness of HCC surveillance with AFP and abdominal ultrasound on mortality in HCV-infected patients found that routine surveillance (6-monthly) was independently associated with a reduced mortality risk (20–30%) when corrected for lead-time with an assumed HCC sojourn time of 70 days.